Your browser doesn't support javascript.
loading
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways.
Therachiyil, Lubna; Hussein, Ola J; Uddin, Shahab; Korashy, Hesham M.
Afiliação
  • Therachiyil L; Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar. Electronic address: lt1904995@student.qu.edu.qa.
  • Hussein OJ; Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar. Electronic address: Olajhussein@gmail.com.
  • Uddin S; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar. Electronic address: SKhan34@hamad.qa.
  • Korashy HM; Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar. Electronic address: hkorashy@qu.edu.qa.
Semin Cancer Biol ; 86(Pt 3): 1186-1202, 2022 11.
Article em En | MEDLINE | ID: mdl-36252938
ABSTRACT
Gynecological malignancies are a female type of cancers that affects the reproductive system. Cancer metastasis or recurrence mediated by cellular invasiveness occurs at advanced stages of cancer progression. Cancer Stem Cells (CSCs) enrichment in tumors leads to chemoresistance, which results in cancer mortality. Exposure to environmental pollutants such as polycyclic aromatic hydrocarbons is associated with an increased the risk of CSC enrichment in gynecological cancers. One of the important pathways that mediates the metabolism and bioactivation of these environmental chemicals is the transcription factor, aryl hydrocarbon receptor (AhR). The present review explores the molecular mechanisms regulating the crosstalk and interaction of the AhR with cancer-related signaling pathways, such as apoptosis, epithelial-mesenchymal transition, immune checkpoints, and G-protein-coupled receptors in several gynecological malignancies such as ovarian, uterine, endometrial, and cervical cancers. The review also discusses the potential of targeting the AhR pathway as a novel chemotherapy for gynecological cancers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 5_ODS3_mortalidade_materna Base de dados: MEDLINE Assunto principal: Receptores de Hidrocarboneto Arílico / Neoplasias dos Genitais Femininos Tipo de estudo: Etiology_studies Limite: Female / Humans Idioma: En Revista: Semin Cancer Biol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 5_ODS3_mortalidade_materna Base de dados: MEDLINE Assunto principal: Receptores de Hidrocarboneto Arílico / Neoplasias dos Genitais Femininos Tipo de estudo: Etiology_studies Limite: Female / Humans Idioma: En Revista: Semin Cancer Biol Ano de publicação: 2022 Tipo de documento: Article